CRO belong to the pharmaceutical Company (CRO b2Ph [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-07-09 00:18 (1097 d 02:25 ago) – Posting: # 23120
Views: 4,365

Hi Captian ElMaestro, Helmut & all,

Should I understand that you think these kinds of studies "performed in CRO belong to the pharmaceutical Company" should be blocked and not accepted due to the high risk of COI and the possibility of manipulating the studies' outcomes.
Is there any guidance, or literature on which we can rely on it to regulate this issue?
Please kindly express your opinion clearly and frankly, it will help a lot.
—
Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,691 registered users;
37 visitors (0 registered, 37 guests [including 15 identified bots]).
Forum time: 02:43 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5